브리티시컬럼비아(B.C.)는 과학적 혁신이 활발한 곳으로 캐나다에서 가장 빠르게 성장하는 생명과학 부문을 자랑합니다. 실제로, 2018년과 2021년 사이에 B.C.에 근거지를 둔 생명과학 기업의 수가 26.5% 증가했습니다. 동 부문의 특징은 인재, 파트너십, 인프라, 투자로 구성된 상호 지원하고 응집력 있는 생태계입니다.
B.C.에는 50개 이상의 생명과학 연구 센터와 여러 우수성 센터 있습니다.
Life Sciences BC(2018-2021)B.C.는 캐나다에서 가장 빠르게 성장한 생명과학 신생 기업들을 보유해 왔음
생명과학 부문 개요(2023년 5월)동 섹터에서 캐나다 전체 주들 가운데 두 번째로 빠른 고용 성장
생명과학 부문 개요(2023년 5월)B.C. is a leading centre for scientific innovation and the sector demonstrates a particular strength in research and development (R&D). Overall, the R&D industry, a subset of the Research, Testing and Medical Laboratories industry group, made up over one-quarter (26%) of the sector’s total employment in 2021, the highest share in Canada.
As British Columbia’s prime location on Canada’s Pacific coast, immediately north of Washington State, provides a natural gateway to Asia as well as easy access to the United States. Collaboration across time zones is made possible by the fact that B.C.’s business day overlaps with morning work schedules in Asia, afternoon working hours in Europe, and is synchronized for the full day with California and Washington State.
Life Sciences businesses in British Columbia benefit from the province’s open and diversified economy, advantageous location, attractive investment climate and skilled workforce. With the B.C. Life Sciences and Biomanufacturing Strategy, the government is positioning B.C. as a global hub for life sciences and biomanufacturing and the development of commercial-scale biopharmaceutical and medical manufacturing. Canadian controlled businesses in B.C. may qualify for a scientific research and experimental development (SR&ED) tax credit top up of 10% if they qualify for the federal government SR&ED tax credit of up to 35%. In addition, the Small Business Venture Capital tax credit encourages investors to make equity capital investments in B.C. small businesses. This gives B.C. entrepreneurs access to early-stage venture capital to help them expand and develop their businesses.
At the forefront of innovation and research in the industry, B.C.’s 25 public post-secondary institutions offer a range of health sciences and applied and natural sciences training programs in areas such as biotechnology, microbiology and immunology, molecular biology, genetics, clinical genetics technology, behavioral neurosciences, and biomedical engineering and technology. The government is investing almost $75M over three years to create 3,000 more tech-learning spaces in the public post-secondary education system. These spaces cover a range of areas including life sciences. The B.C. Future Ready Action Plan will provide grants for new training opportunities, create more tech-relevant post-secondary spaces to meet demands, and address barriers to access education and skills training. In addition, the new National Biomanufacturing Training Centre located on the campus of the BC Institute of Technology, will offer hands-on biomanufacturing training to current and future industry employees.
B.C.’s life sciences sector is highly collaborative and supported by industry organizations and accelerators, governmental organizations, universities and research hospitals, and other organizations that co-ordinate and fund research and clinical trials. The new Clinical Support and Research Centre (CSRC) at the new St. Paul’s Hospital in Vancouver, will bring medical staff and researchers together – along with academic, industry researchers to explore new frontiers in bioengineering, nanotechnology, virtual reality, augmented reality and simulation. The partnerships forged in the province between researchers, academia, clinicians and industry, community organizations and government agencies facilitate the development, transfer and commercialization of knowledge.
우리의 무역투자청 담당자가 귀사가 올바른 관계를 구축하고, 이벤트 및 무역 박람회에 참여하고, 프로그램과 이니셔티브를 탐색하는 데 도움을 드립니다. 가까운 곳의 전문가와 만나보세요.